Topic: United States
LONDON (Reuters) - Educated people are better able to cope with the physical effects of dementia, and even one extra year of education can significantly cut the risk of developing the brain-wasting disease, scientists said on Monday. The findings by scientists from ...
HONOLULU (Reuters) - Identifying dementia early can cut the cost of care by nearly 30 percent, U.S. researchers said on Wednesday, a finding that may reduce the heavy financial burden of the disease on the health care system. They said routine screening ...
LONDON (Reuters) - Scientists have identified changes in mouse brains that impair learning, and say the findings mean drugs being developed for some cancers may also help fight age-related diseases like dementia and Alzheimer's. German researchers studying mice at difference ages found ...
A widely-prescribed drug to tackle high blood pressure and heart disease also appears to reduce the risk of Alzheimer's and other forms of dementia, according to a large US study published on Wednesday. US military veterans who took angiotensin receptor blockers (ARBs) ...
LONDON (Reuters) - Medicines commonly used to treat high blood pressure and heart disease may cut the risk of developing Alzheimer's disease and dementia, U.S. scientists said on Wednesday. Researchers from Boston found that older people taking a certain type of blood ...
CHICAGO (Reuters) - Strong warnings about the dangers of giving antipsychotic drugs to patients with dementia have reduced use of the drugs in these patients by a "modest" 19 percent, U.S. researchers said on Monday. Studies have shown that using antipsychotic drugs ...
Widely used supplement not effective in reducing dementia Lots of older adults who purchase the herbal supplement Ginkgo biloba, in hopes it will keep them mentally sharp, may be wasting their money. That's the finding of researchers reporting their results in the ...
The herbal supplement ginkgo biloba does not slow cognitive decline, a study published Tuesday in the Journal of the American Medical Association (JAMA) said. Researchers from the University of Pittsburgh analyzed data in an eight-year randomized, double-blind placebo-controlled trial called the Ginkgo ...
WASHINGTON (Reuters) - The widely used herbal supplement Ginkgo biloba does not appear to slow the rate of cognitive decline in healthy older people or those with mild cognitive impairment, U.S. researchers said on Tuesday. Their study involved 3,069 people age 72 ...
A person's risk of contracting Alzheimer's may be linked to levels of the appetite-suppressing hormone leptin, according to a US study published Wednesday which could point the way toward future treatment of the disease. The Journal of the American Medical Association (JAMA) ...
